PEOPLE - Symphony Medical makes appointment:
This article was originally published in Clinica
Executive Summary
Raymond Cohen has been appointed CEO and a member of the board of directors for Symphony Medical (Laguna Hills, California). Mr Cohen joins the biotherapeutic products firm from Cardiac Science - a manufacturer of automatic public-access defibrillators - where he was CEO for nine years. He is a director at BioLife Solutions (cryopreservation products for human cell and tissue preservation) and Syncroness (contract engineering and product development), and acts as advisor for the College of Osteopathic Medicine, Western University of Health Sciences (California).
You may also be interested in...
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.